David Ghiyam

Because they need the wonderful information that you're giving them. It's not a moneymaker, face it. But that's our obligation. Absolutely. How long, you say your dad died of Alzheimer's, is that right? Alzheimer's killed him. And I think it's really important that people understand that Alzheimer's itself is the number three cause of death in America. It kills people.

Because they need the wonderful information that you're giving them. It's not a moneymaker, face it. But that's our obligation. Absolutely. How long, you say your dad died of Alzheimer's, is that right? Alzheimer's killed him. And I think it's really important that people understand that Alzheimer's itself is the number three cause of death in America. It kills people.

Now, to be clear, Alzheimer's patients generally have quite a few other diseases going on because they're metabolically compromised, heart disease, diabetes, etc. Becoming a type 2 diabetic is associated with about a four-fold increased risk of Alzheimer's. So these things ride together, but it was clearly the Alzheimer's that took his life.

Now, to be clear, Alzheimer's patients generally have quite a few other diseases going on because they're metabolically compromised, heart disease, diabetes, etc. Becoming a type 2 diabetic is associated with about a four-fold increased risk of Alzheimer's. So these things ride together, but it was clearly the Alzheimer's that took his life.

Well, how long had he had the clinical manifestations? Probably about seven years. But vis-a-vis our earlier discussions, it likely started 20, 25 years earlier than that.

Well, how long had he had the clinical manifestations? Probably about seven years. But vis-a-vis our earlier discussions, it likely started 20, 25 years earlier than that.

Well, I diagnosed it. Wow. And I remember the moment I diagnosed it. And at that moment, I said to myself, how could I have ignored this as a neurologist? And of course I would ignore it. It's my father for crying out loud. But it's my work. I did it every day. I made that diagnosis countless times every single day in my medical practice.

Well, I diagnosed it. Wow. And I remember the moment I diagnosed it. And at that moment, I said to myself, how could I have ignored this as a neurologist? And of course I would ignore it. It's my father for crying out loud. But it's my work. I did it every day. I made that diagnosis countless times every single day in my medical practice.

You don't want to see that with your father, so maybe you're not looking. I didn't want to see it. I couldn't see it. I kept myself from seeing it. But finally, in one statement that he made, I was about to argue with him that he was wrong, that dad, no, as a matter of fact it was a different way when I finally got it and I said, wow, this is where we are.

You don't want to see that with your father, so maybe you're not looking. I didn't want to see it. I couldn't see it. I kept myself from seeing it. But finally, in one statement that he made, I was about to argue with him that he was wrong, that dad, no, as a matter of fact it was a different way when I finally got it and I said, wow, this is where we are.

Wow.

Wow.

You'd think I was the oldest. I get that all the time. You know, you must be.

You'd think I was the oldest. I get that all the time. You know, you must be.

Yeah.

Yeah.

And get to work. Get to work. So, yeah, you know, I've devoted myself to this notion. And we're living in a world that, again, wants us to believe that our lifestyle choices don't matter. They're everything. They're everything. This disease is not caused primarily by an accumulation of beta amyloid.

And get to work. Get to work. So, yeah, you know, I've devoted myself to this notion. And we're living in a world that, again, wants us to believe that our lifestyle choices don't matter. They're everything. They're everything. This disease is not caused primarily by an accumulation of beta amyloid.

It's the targeting of beta-amyloid that is the focus of all these wonderful new drugs that are being FDA approved. They aren't working. It's a metabolic issue. That's what I yell from the mountaintop. And we've got to rein in our metabolism to help keep the brain healthy and resistant to the problem in the first place. And also as a therapeutic intervention.

It's the targeting of beta-amyloid that is the focus of all these wonderful new drugs that are being FDA approved. They aren't working. It's a metabolic issue. That's what I yell from the mountaintop. And we've got to rein in our metabolism to help keep the brain healthy and resistant to the problem in the first place. And also as a therapeutic intervention.